1. Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. (December 2016) Authors: Ylstra, B.; Cordes, M.; Biesma, H.D.; Verheul, H.M.; Neerincx, M.; Koopman, M.; Punt, C.J.; Meijer, G.A.; Murphy, V.; Barat, A.; Betge, J.; Ebert, M.; Gaiser, T.; Fender, B.; Klinger, R.; Das, S.; Smeets, D.; Lambrechts, D.; Byrne, A.T.; Van Grieken, N.C.T. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Functional genomic screening identifies USP11 as a novel therapeutic target in breast cancer. (July 2016) Authors: Dwane, L.; O'Connor, A.; Mulrane, L.; Klinger, R.; Dirac, A.; Jirstrom, K.; Crown, J.; Bernards, R.; Gallagher, W.; O'Connor, D. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment history and placebo responses to experimental and clinical pain in chronic pain patients. (7th April 2016) Authors: Müller, M.; Kamping, S.; Benrath, J.; Skowronek, H.; Schmitz, J.; Klinger, R.; Flor, H. Journal: European journal of pain Issue: Volume 20:Number 9(2016) Page Start: 1530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗